Is INDP or INDV more undervalued in 2026?

CirclFi compares Indaptus Therapeutics, Inc. (INDP) and Indivior Pharmaceuticals, Inc. (INDV) using 13 institutional-grade valuation models. INDP has a Quality of Company score of 2.5/10 while INDV scores 5.9/10.

Which is a better buy — INDP or INDV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INDP and INDV valuations compare?

INDP at $1.76 and INDV at $36.02 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INDP vs INDV Valuation Comparison 2026 — Intrinsic Value Analysis

INDP

Pharmaceutical Preparations

Indaptus Therapeutics, Inc.

Quality

2.5

out of 10

Value Trap

LOW

Price

$1.76

Last close

Models

4/13

Active

INDV

Pharmaceutical Preparations

Indivior Pharmaceuticals, Inc.

Quality

5.9

out of 10

Value Trap

SAFE

Price

$36.02

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	INDP Fair Value	INDP Upside	INDV Fair Value	INDV Upside
Bayesian DCF	Intrinsic	$0.05	-97.1%	$8.35	-76.8%
Earnings Power Value	Intrinsic	—	—	$18.45	-48.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.21	-90.3%	$78.30	+117.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INDP vs INDV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INDP vs INDV — Which Stock Is More Undervalued?

INDV scores higher with a 5.9/10 quality rating vs INDP's 2.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Indaptus Therapeutics, Inc. (INDP) and Indivior Pharmaceuticals, Inc. (INDV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INDP currently trades at $1.76 with a QOC of 2.5/10, while INDV trades at $36.02 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).